Stockscreener 앱 받기
1.56
4.00%
0.06
시간 외 거래:
1.56
Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스
Federated Hermes Inc. Invests $285,000 in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - MarketBeat
William Blair Has Positive Estimate for NMRA FY2029 Earnings - MarketBeat
Neumora's Q2 2025 Earnings Call: Unpacking Key Contradictions in M4 PAM Safety, Obesity Focus, and KOASTAL Studies - AInvest
Q3 EPS Estimate for Neumora Therapeutics Boosted by Analyst - MarketBeat
Neumora Therapeutics reports Q2 EPS (33c), consensus (37c) - MSN
Elevidys sales weaken; Neumora gets into obesity - BioPharma Dive
Neumora Therapeutics Faces Challenges as It Transitions to Full Public Company Compliance - TipRanks
Neumora Therapeutics’ Earnings Call Highlights Promising Pipeline - TipRanks
Neumora outlines six upcoming clinical catalysts and prioritizes obesity program with NMRA-215 - MSN
Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00 By Investing.com - Investing.com Canada
Promising Developments and Pipeline Progress Drive Buy Rating for Neumora Therapeutics - TipRanks
Neumora Therapeutics, Inc.: Promising Potential in Obesity Therapeutics with NMRA-215 - TipRanks
Earnings call transcript: Neumora Therapeutics beats Q2 2025 EPS estimates - Investing.com
Neumora Therapeutics Reports Q2 2025 Financial Results - TipRanks
Neumora Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Neumora Targets $180B Obesity Market with New Brain-Penetrant Drug, Reports 6 Clinical Readouts Coming - Stock Titan
Neumora Therapeutics to Report Q2 2025 Financial Results on August 6, 2025 - AInvest
Neumora Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
How volatile is Neumora Therapeutics Inc. stock compared to the marketUnprecedented market success - Jammu Links News
Why is Neumora Therapeutics Inc. stock attracting strong analyst attentionSignificant capital appreciation - Jammu Links News
Does Neumora Therapeutics Inc. stock perform well during market downturnsCapitalize on fast-growing stocks today - Jammu Links News
How does Neumora Therapeutics Inc. generate profit in a changing economyCapitalize on market trends with expert guidance - Jammu Links News
Is it the right time to buy Neumora Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News
What institutional investors are buying Neumora Therapeutics Inc. stockAchieve triple-digit returns with smart investing - Jammu Links News
What are the latest earnings results for Neumora Therapeutics Inc.Capitalize on market momentum for maximum profit - Jammu Links News
What are analysts’ price targets for Neumora Therapeutics Inc. in the next 12 monthsAI Powered Tips With High Returns - Jammu Links News
Neumora Therapeutics (NMRA) Projected to Post Earnings on Wednesday - MarketBeat
How strong is Neumora Therapeutics Inc. company’s balance sheetExpert Picks Entry Points For 2025 - Jammu Links News
What is the dividend policy of Neumora Therapeutics Inc. stockPost Market Planner That Work - Jammu Links News
How many analysts rate Neumora Therapeutics Inc. as a “Buy”Chart Pattern Updates For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Neumora Therapeutics Inc.Chart Pattern Guidance To Watch Now - Jammu Links News
Key metrics from Neumora Therapeutics Inc.’s quarterly dataTrade Insight With Community Collaboration Supported - metal.it
What are Neumora Therapeutics Inc. company’s key revenue driversAI Powered Planner Backed By Experts - Jammu Links News
Why Neumora Therapeutics Inc. stock attracts strong analyst attentionStrong Buy With Technical Confidence Supported - beatles.ru
Published on: 2025-07-30 12:15:41 - metal.it
Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating - MSN
Mizuho Boosts Neumora Price Target to $5, Maintains Outperform Rating - AInvest
Pegasystems Delivers Strong Q2 Results, Raises Price Target to $58 - AInvest
Published on: 2025-07-29 01:24:00 - metal.it
What is Neumora Therapeutics Inc. company’s growth strategyNavigate market volatility with smart strategies - jammulinksnews.com
When is Neumora Therapeutics Inc. stock expected to show significant growthCapitalize on market trends with expert guidance - Jammu Links News
1.67%
자본화:
|
볼륨(24시간):